Isothermal Nucleic Acid Amplification Technology (INAAT) Market Is Projected To Grow At A CAGR Of 11.8% During Forecast Period 2014-2025

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is expected to reach USD 4.3 billion by 2025, growing at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. This can be attributed to significant rise in awareness regarding need for rapid and on-time testing for chronic and infectious diseases. Global increase in adoption of INAAT for detection of HIV, hepatitis A & B, and sexually transmitted diseases is considered to be a high impact rendering driver for growth.

Loop-Mediated Isothermal Amplification is one of the most preferred nucleic acid amplification methods because of its ability to provide point of care testing, thus leading to increased adoption. The recently-introduced Nicking Enzyme Amplification Reaction (NEAR) and Helicase-dependent amplification (HDA) technologies are expected to experience exponential growth during the forecast period owing to their patent protection.

In addition, owing to recent epidemics of infectious diseases, such as tuberculosis, Zika virus, and influenza, importance of point of care diagnosis has increased especially in developing countries. This is also anticipated to boost demand for this technology in these regions.

Full Research Report on Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market

Further Key Findings From the Report Suggest:

• Reagents are expected to be fastest growing products owing to their high usage in all INAAT procedures
• TMA was identified as the largest technology segment by revenue share in 2016 owing to its high adoption
• Infectious disease diagnostics is expected to be the fastest growing application owing to development of numerous assays for detection of specific infectious diseases
• Hospitals dominated the end user segment in 2016 with the largest share and are expected to be continue dominance over the forecast period owing to the high usage of INAAT in hospitals globally
• North America held the largest share of the global market in 2016, and the U.S. held the largest revenue share in the region owing to rise in infectious diseases, availability of government funds, prevalence of cancer, application of MDx in cancer screening & genetic disorders, and self-monitoring techniques
• The molecular diagnostics industry in Asia Pacific is projected to witness substantial growth over the next decade due to various developments in major economies, especially in the NASBA, NEAR, and HDA technology segments
• Some of the key players in the INAAT market include Alere; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; ThermoFisher Scientific; and Becton, Dickinson & Company
• Major players have been engaging in numerous strategic initiatives such as mergers and acquisitions to increase global presence and improve market share.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market on the basis of product, technology, application, end-use, and region:

Isothermal Nucleic Acid Amplification By Product Outlook (Revenue, USD Million, 2014 - 2025)

• Instrument
• Reagent

Isothermal Nucleic Acid Amplification By Technology Outlook (Revenue, USD Million, 2014 - 2025)

• NASBA
• HDA
• LAMP
• SDA
• SPIA
• NEAR
• TMA
• RCA
• RPA
• SMAP2
• Others

Isothermal Nucleic Acid Amplification By Application Outlook (Revenue, USD Million, 2014 - 2025)

• Blood screening
• Infectious disease diagnostics
• Cancer
• Others

Isothermal Nucleic Acid Amplification By End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals,
• Central and reference labs
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release of This Research Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-isothermal-nucleic-acid-amplification-technology-inaat-market 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Protein Purification And Isolation Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

Global Protein Purification And Isolation Market is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market. 

Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques.

Full Research Report on Global Protein Purification And Isolation Market Analysis:
http://www.grandviewresearch.com/industry-analysis/protein-purification-isolation-market

Further Key Findings From the Report Suggest:

• Reagents were observed to be the largest as well as the fastest growing segment under the product outlook. These are highly used during cell lysis and help in separating soluble proteins from the cell debris.
• Increasing adoption of automated protein purification techniques for achieving desired purity & process consistency and saving time is estimated to result in stable growth of the segment
• On the basis of technology, chromatography held a significant share of the market owing to factors such as high reliability, availability of a wide range of products, and improved results for purifying complex proteins.
• High R&D initiatives undertaken by market players for the screening of potential drugs through protein-protein interaction and structure-based studies is estimated to contribute toward fastest growth of the drug screening segment
• By end use, CROs are considered as the fastest growing segment. Increase in investments in the R&D sector is expected to contribute toward market growth
• In 2016, North America held the largest share owing to advancements in the technology, presence of major players, and established infrastructure especially in this region, which acts as a driving force to the market
• The highest CAGR is anticipated in Asia Pacific over the forecast period due to a rise in economic stability, increasing number of CROs, and growing R&D in academic & research institutes
• Some of the key players of this market are Thermo Fisher Scientific; Merck KGaA; Sigma-Aldrich Co.; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies; Promega Corporation; GE Healthcare; Norgen Biotek Corporation; and Abcam plc.
• Some of the strategies implemented by these companies are mergers & acquisitions, strategic collaborations, and expansion of product portfolio through R&D initiatives, which have helped the market grow.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Global Protein Purification And Isolation Market on the basis of products, technology, application, end use, and region:

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Instruments
• Consumables
• Kits
• Reagents
• Columns
• Magnetic beads
• Resins
• Others

Technology Outlook (Revenue, USD Million; 2014 - 2025)

• Ultrafiltration
• Precipitation
• Chromatography
• Ion exchange chromatography
• Affinity chromatography
• Reversed phase chromatography
• Size exclusion chromatography
• Hydrophobic interaction chromatography
• Electrophoresis
• Gel electrophoresis
• Isoelectric focusing
• Capillary electrophoresis
• Western Blotting
• Others

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Drug screening
• Biomarker discovery
• Protein-protein interaction studies
• Diagnostics

End-use Outlook (Revenue, USD Million; 2014 - 2025)

• Academic and research institutes
• Hospitals
• Pharmaceutical and biotechnological companies
• CROs

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Press Release of This Research Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-protein-purification-isolation-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Automotive Coatings Market Analysis By Product, Technology, Application, End-Use, And Segment Forecasts 2014-2025

Global Automotive Coatings Market is expected to reach USD 36.31 billion by 2025, according to a new report published by Grand View Research, Inc. Surging demand for both passenger and commercial automobiles in emerging countries including China, India, Mexico, Brazil, and South Africa on account of population growth and developing living standards is expected to augment market size over the forecast period. Moreover, increasing requirement of protection against harsh climate, dust, dirt, UV radiation, and acid rain is expected to aid in industry expansion.

Growing number of accident in countries including India and Brazil owing to adverse road conditions in mountainous areas is anticipated to fuel the demand for these products over the upcoming years. Moreover, increasing requirement of maintenance, repair, and refurbishing work of old vehicles is expected to stimulate growth.

Rising consumption of powder coatings in light of its superior properties, such as near zero volatile organic compound emissions and thicker layer compared to conventional coatings, is expected to increase market size. Furthermore, continuous investments by manufacturers along with increasing number of manufacturing facilities in Brazil and China will drive growth over the forecast period.

Full Research Report on Global Automotive Coatings Market Analysis: http://www.grandviewresearch.com/industry-analysis/automotive-coatings-market

Further key findings from the report suggest:

• The global automotive coatings industry demand was 5,902.7 kilo tons in 2015 and is expected to grow significantly on account of increasing vehicle production in rapidly emerging countries including China, Japan, India, Mexico, Brazil, South Korea, Brazil, and South Africa
• Waterborne coatings market demand is anticipated to witness strong growth in light of stringent regulations pertaining to the usage of solvent borne technology. In addition, superior properties, such as corrosion resistance, flexibility, hardness, stain resistance, adhesion, low flammability, and toxicity, are expected to surge product demand over the next nine years.
• North America contributed to 22.7% of the overall revenue share in 2015 and is estimated to witness growth on account of rising demand for pickup trucks and utility vehicles in the region
• Central and South America is expected to see substantial revenue rise at a CAGR of 5.4% from 2016 to 2025 owing to increasing small car production in Brazil. Furthermore, large automobile manufacturers including General Motors, Volkswagen, and Hyundai have been shifting their base to the region owing to lower operation costs, which is likely to aid in market expansion.
• The industry is highly competitive in nature, and manufacturers are involved in continuous product development and R&D activities. Manufacturers including Axalta Coating Systems, PPG Industries, BASF, Nippon Paint, AkzoNobel, and Kansai Paint are some of the key players in the market.
• In April 2015, Axalta established a new R&D technology center in Shanghai to develop new products for the global commercial vehicle, light vehicle OEM, refinish and industrial customers

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Automotive Coatings Market on the basis of product, technology, application, end-use, and region:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Primer
• Electro coat
• Basecoat
• Clear coat

Technology Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Waterborne Coatings
• Solvent borne Coatings
• Powder Coatings
• UV-cured Coatings

Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Metal Parts
• Plastic Parts

End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Light Vehicle OEM
• Commercial Vehicle OEM
• Automotive Refinish

Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Central & South America
• Brazil
• MEA

View Blog on This Research Report by Grand View Research: http://www.grandviewresearch.com/blog/automotive-coatings-market-size-share

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

3D Printing Market Analysis By Application, Raw Material And Segment Forecast Up To 2020

Global 3D Printing Market was estimated to be USD 2,183 million in 2012, and is expected to reach USD 8,675.7 million by 2020, as per a new study by Grand View Research, Inc. The ability to facilitate low-volume manufacturing in a cost-effective manner is expected to fuel the market over the next few years. Further, the report analyses that the growing need for flexible and customized products is expected to positively impact demand for 3D printing.

Automotive and healthcare industries in particular, are estimated to be key growth areas for revenue generation. Automotive is expected to be the largest and fastest growing application, with an estimated CAGR of 19.6% from 2013 to 2020. The market for medical applications was valued at USD 397.2 million in 2012, with dental applications expected to contribute largely to this segment. Concerns over protection of intellectual property from products manufactured using 3D printing are expected to restrain the industry from reaching its target potential. Backward integration in the value chain in terms of acquisitions of software 3D designing participants has been analyzed to be an opportunity for gaining competitive advantage.

Full Research Report On Global 3D Printing (3DP) Market Analysis: http://www.grandviewresearch.com/industry-analysis/3d-printing-industry-analysis

Further Key findings from the study suggest:

• North America led the market, with approximately 42% of the overall market share in 2012
• Europe is expected to grow at the highest CAGR of 20.4% from 2013 to 2020, which can primarily be attributed to increase in funding from regulatory bodies. Furthermore, increasing investment in research and development are expected to be favorable factors for market expansion in this region
• In terms of raw material used for manufacturing, polymers are expected to dominate the market, and accounted for more than 35% of the overall revenue in 2012
• The industry is moderately consolidated, with mergers and acquisitions emerging as the key growth strategy. Major industry participants include Stratasys Inc., 3D Systems Corporation, Envisiontec GmbH, and Materialise NV among others.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research’s report estimates the market in terms of revenue (USD Million) and segments it as follows:

3D Printing Application Outlook:

• Automotive
• Aerospace
• Consumer Products
• Medical
• Others

3D Printing Raw Material Outlook:

• Polymers
• Metals
• Ceramic
• Others

3D Printing Regional Outlook:

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

View Blog on Global 3D Printing (3DP) Market by Grand View Research: http://www.grandviewresearch.com/blog/3d-printing-industry   

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Live Cell Imaging Market Is Projected To Reach USD 9.0 billion by 2025

Global Live Cell Imaging Market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. 

Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

Full Research Report on Global Live Cell Imaging Market Analysis: http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings From The Report Suggest:

• Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.
• Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.
• North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.
• Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.
• Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Live Cell Imaging Market on the basis of product, application, technology, and region:

Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

• Equipment
• Consumable
• Software

Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• MEA
• South Africa 

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-live-cell-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mixed Tocopherols Market Is Anticipated To Observe Sluggish Growth At A CAGR Of 2.4% From 2017 To 2025

Global Mixed Tocopherols Market is expected to reach USD 11.9 billion by 2025, according to a new report by Grand View Research, Inc. Rising vitamin E demand in food and dietary supplements owing to rising health concerns is expected to plays a significant role in promoting the industry growth over the next few years. The global market is anticipated to observe sluggish growth at a CAGR of 2.4% from 2017 to 2025.

Alpha rich tocopherols was the leading product segment and is anticipated to grow at a CAGR of 2.3%, by revenue, over the forecast period. The segment is expected to gain share over the forecast period owing to high demand in dietary supplements. Health benefits associated with vitamin E to treat deficiency and diseases such as lung, oral, colorectal and pancreatic cancer; polyps, and gastric are also anticipated to drive the mixed tocopherols market in pharmaceuticals over the forecast period.

Full Research Report on Global Mixed Tocopherols Market Analysis:http://www.grandviewresearch.com/industry-analysis/mixed-tocopherols-industry

Further key findings from the report suggest:

• The global mixed tocopherols demand was 117.8 kilo tons in 2016 and is estimated to grow at a CAGR of 3.6% from 2017 to 2025
• Mixed tocopherols demand in dietary supplements was 50.9 kilo tons in 2016 and is anticipated to witness moderate growth over the next eight years
• Product demand in animal feed nutrition is anticipated to emerge as the fastest growing application segment, and generate revenues worth over USD 2 billion by 2025
• Mixed tocopherols demand in North America is projected to reach USD 3.6 billion by 2025 and is estimated to grow as a significant rate from 2017 to 2025
• The U.S. gamma rich tocopherols demand is anticipated to emerge as the fastest growing market in North America and is expected to reach total volume of over 5.6 kilo tons by 2025
• The industry in Europe is projected to witness moderate growth of 2.9% from 2017 to 2025 owing to the increased use of mixed tocopherols as antioxidants and feed additives
• Asia Pacific was the dominant consumer in 2016. High rate of dietary supplements, animal feed, and pharmaceuticals manufacturing in key economies including China, Japan, and India is the major factor for industry penetration.
• Key industry participants such as BASF, DSM, ADM, and Cargill dominated the global mixed tocopherol market over the next few years. The major players operating in the mixed tocopherol market comprise, BTSA, Vitae Naturals, Zhejiang Medicine Co., Ltd. (ZMC), COFCO Tech Bioengineering Co., Ltd., Eisai Food & Chemical Co., Ltd., and Vance Group Ltd.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/food-additives-nutricosmetics-flavors-and-fragrances

Grand View Research has segmented the Global Mixed Tocopherols Market on the basis of product, application, and region:

Mixed Tocopherols Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Alpha Rich
• Gamma Rich
• Gamma-Delta Rich
• Others

Mixed Tocopherols Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Dietary Supplements
• Animal Feed Nutrition
• Cosmetics
• Pharmaceuticals
• Food & Beverage Fortification

Mixed Tocopherols Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-mixed-tocopherols-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Narcolepsy Therapeutics Market Size Projected To Reach $3.85 Billion By 2025

Global Narcolepsy Therapeutics Market is expected to reach USD 3.85 billion by 2025, according to a new report by Grand View Research, Inc. The increasing awareness about this sleep disorder among public and healthcare providers is a key factor contributing to the market growth.

The Narcolepsy Network has estimated that out of every 2,000 people 1 is afflicted by this condition. Moreover, Narcolepsy UK states that around 25% patients are identified and remaining 75% are untreated as they remain undiagnosed or are misdiagnosed, which is alarming. Some organizations and networks are constantly working to spread awareness about this condition among the patients and physicians.

Full Research Report on Global Narcolepsy Therapeutics Market Analysis:  
http://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market

Further key findings from the report suggest:

• The narcolepsy therapeutics market is expected to grow substantially owing to the worldwide increasing incidence of this disorder.
• Narcolepsy with cataplexy was identified as the largest type segment in 2016. It is expected to retain its position throughout the forecast period owing to the rising cases of cataplexy in patients suffering from narcolepsy.
• Narcolepsy without cataplexy is likely to witness the fastest growth over the forecast period due to increasing awareness about Excessive Daytime Sleepiness (EDS) through various mediums, such as awareness campaigns
• Sodium oxybate dominated the product segment in terms of revenue share in the year 2016, and it is also expected to be the fastest growing segment over the forecast period. Drugs belonging to this class have higher costs and favorable coverage policies.
• Xyrem is the only FDA-approved drug in this category and is extensively prescribed for the treatment of cataplexy and EDS. American Academy of Sleep Medicine (ASSM) recommends it as a standard treatment of this disorder.
• Europe dominated the regional market in terms of revenue share in 2016 because of increase in capital investments and existence of established healthcare infrastructure along with a large target population
• The H1N1 influenza postvaccination pandemic of the year 2009 has resulted in growth of number of narcolepsy patients
• Asia Pacific is likely to exhibit fastest growth during the forecast period due to the rising healthcare expenditure in this region, rising awareness among people, highest prevalence in Japan, and presence of emerging economies such as China & India
• Some of the major market players are Jazz Pharmaceuticals PLC;Teva Pharmaceutical Industries Ltd.;Graymark Healthcare, Inc.;Addrenex Pharmaceuticals, Inc.; and BIOPROJET.
• Mergers and acquisitions are strategic initiatives undertaken by these market players in an attempt to remain competitive. In addition, companies are expanding their geographical presence to untapped markets.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Narcolepsy Therapeutics Market on the basis of type, product, and region:

Narcolepsy Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)

• Narcolepsy with Cataplexy
• Narcolepsy Without Cataplexy
• Secondary Narcolepsy

Narcolepsy Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)

• Central Nervous System Stimulants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor
• Tricyclic Antidepressants
• Others

Narcolepsy Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-narcolepsy-therapeutics-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com